Warning! GuruFocus detected
1 Medium warning sign
with PVLA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Palvella Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US6979471090
Description
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.71 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.45 | |||||
| 9-Day RSI | 48.78 | |||||
| 14-Day RSI | 50.33 | |||||
| 3-1 Month Momentum % | 122.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.33 | |||||
| Quick Ratio | 7.33 | |||||
| Cash Ratio | 6.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -59.37 | |||||
| ROA % | -36.4 | |||||
| ROIC % | -428.16 | |||||
| ROCE % | -32.23 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.4 | |||||
| Price-to-Tangible-Book | 4.4 | |||||
| EV-to-EBIT | -14.95 | |||||
| EV-to-Forward-EBIT | -3.19 | |||||
| EV-to-EBITDA | -14.95 | |||||
| EV-to-FCF | -18.1 | |||||
| Price-to-Net-Current-Asset-Value | 4.4 | |||||
| Price-to-Net-Cash | 4.75 | |||||
| Earnings Yield (Greenblatt) % | -6.69 | |||||
| FCF Yield % | -4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PVLA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Palvella Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -7.83 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 50.33 | ||
| 14-Day ATR ($) | 2.42314 | ||
| 20-Day SMA ($) | 24.1225 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 11.17 - 29.27 | ||
| Shares Outstanding (Mil) | 11.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Palvella Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Palvella Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Palvella Therapeutics Inc Frequently Asked Questions
What is Palvella Therapeutics Inc(PVLA)'s stock price today?
The current price of PVLA is $24.57. The 52 week high of PVLA is $29.27 and 52 week low is $11.17.
When is next earnings date of Palvella Therapeutics Inc(PVLA)?
The next earnings date of Palvella Therapeutics Inc(PVLA) is 2025-05-30 Est..
Does Palvella Therapeutics Inc(PVLA) pay dividends? If so, how much?
Palvella Therapeutics Inc(PVLA) does not pay dividend.
Guru Commentaries on NAS:PVLA
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers